Investigators extracted data from the Adolescent Behavior Cognition Development (ABCD) study, a longitudinal cohort study that enrolled children aged 9 to 10 years at baseline from 21 sites around the US.
The approval was based on data from a phase 3 trial that assessed Qelbree in adults 18 to 65 years of age with ADHD.
An investigator at the University of Liverpool searched publication databases through 2020 for studies of dermatoglyphics, digit ratio, and palmar crease in conjunction with mental illness.
Investigators from the Mayo Clinic searched publication databases with the goal of understanding how wearable devices were being used in child psychiatry research and how the understanding of pediatric psychiatric disorders has been enhanced by artificial intelligence technologies.
Authors analyzed the documentation of primary care professionals from electronic health records (EHRs) to find out the rate of PTBM recommendation for 4-5 year old patients with an ADHD diagnosis, ADHD symptoms or who were prescribed ADHD medication.
Study researchers investigated the genetic overlap between ADHD and autism to determine if shared gene variants may provide insight into treatment targets.
Azstarys consists of serdexmethylphenidate, a prodrug of dexmethylphenidate, co-formulated with immediate-release dexmethylphenidate.
The sNDA approval was based on data from a phase 3 Adult Laboratory Classroom study that assessed the efficacy and safety of Adhansia XR in adults diagnosed with ADHD.
There have not been very many studies which examined the association between secondhand smoke and ADHD symptoms in children. Thus, the researchers sought to evaluate whether or not there is a relationship between the two.
This genome-wide associated study expanded on the gene-environment correlation for childhood maltreatment and causal relationship between childhood maltreatment and health.
